Key Insights

Highlights

Treatment Research

2 treatments under study, led by Adenosine Deaminase Acting On Rna1

Research Leaders

5 sponsors active, led by Varian Medical Systems

Related Conditions

Often studied with 4 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 3 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

1Total
Phase 1 (1)

Trial Status

Recruiting2
Unknown1

Clinical Trials (3)

Showing 3 of 3 trials
NCT07221058Phase 1RecruitingPrimary

Adaptive Radiation Boost for Rectal Cancer

NCT07108348RecruitingPrimary

ADAR1 Expression Level in Rectal Cancer

NCT02979470Unknown

Study of Blood Components as Probable Prognostic and Predictive Markers of Response to Treatment in Advanced Colon and Rectal Cancers

Showing all 3 trials

Research Network

Common Treatments

  • Adenosine Deaminase Acting On Rna11
  • Adaptive Radiotherapy Boost1

Active Sponsors

  • Varian Medical Systems1
  • AC Camargo Cancer Center1
  • Necmettin Erbakan University1
  • Fox Chase Cancer Center1
  • Turkish Society of Medical Oncology1

Top Investigators

Related Conditions

  • Colon Cancer Stage Iiic1
  • Colon Cancer Stage Iiib1
  • Colon Cancer Stage Iiia1
  • Colon Cancer Stage Iib1

Activity Timeline